Copyright Reports & Markets. All rights reserved.

Global Medically Assisted Reproduction Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Medically Assisted Reproduction Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medically Assisted Reproduction Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Ovulation Stimulation Drugs
    • 1.3.3 Luteal Support Medications
    • 1.3.4 Downregulatory Drugs
    • 1.3.5 Ovulation Inducing Drugs
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medically Assisted Reproduction Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Research Institute
    • 1.4.4 Others
  • 1.5 Global Medically Assisted Reproduction Drugs Market Size & Forecast
    • 1.5.1 Global Medically Assisted Reproduction Drugs Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Medically Assisted Reproduction Drugs Sales Quantity (2018-2029)
    • 1.5.3 Global Medically Assisted Reproduction Drugs Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Merck Serono
    • 2.1.1 Merck Serono Details
    • 2.1.2 Merck Serono Major Business
    • 2.1.3 Merck Serono Medically Assisted Reproduction Drugs Product and Services
    • 2.1.4 Merck Serono Medically Assisted Reproduction Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Merck Serono Recent Developments/Updates
  • 2.2 MSD
    • 2.2.1 MSD Details
    • 2.2.2 MSD Major Business
    • 2.2.3 MSD Medically Assisted Reproduction Drugs Product and Services
    • 2.2.4 MSD Medically Assisted Reproduction Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 MSD Recent Developments/Updates
  • 2.3 Livzon Pharmaceutical
    • 2.3.1 Livzon Pharmaceutical Details
    • 2.3.2 Livzon Pharmaceutical Major Business
    • 2.3.3 Livzon Pharmaceutical Medically Assisted Reproduction Drugs Product and Services
    • 2.3.4 Livzon Pharmaceutical Medically Assisted Reproduction Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Livzon Pharmaceutical Recent Developments/Updates
  • 2.4 Xianju Pharmaceutical
    • 2.4.1 Xianju Pharmaceutical Details
    • 2.4.2 Xianju Pharmaceutical Major Business
    • 2.4.3 Xianju Pharmaceutical Medically Assisted Reproduction Drugs Product and Services
    • 2.4.4 Xianju Pharmaceutical Medically Assisted Reproduction Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Xianju Pharmaceutical Recent Developments/Updates
  • 2.5 Kinsey Pharmaceuticals
    • 2.5.1 Kinsey Pharmaceuticals Details
    • 2.5.2 Kinsey Pharmaceuticals Major Business
    • 2.5.3 Kinsey Pharmaceuticals Medically Assisted Reproduction Drugs Product and Services
    • 2.5.4 Kinsey Pharmaceuticals Medically Assisted Reproduction Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Kinsey Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Medically Assisted Reproduction Drugs by Manufacturer

  • 3.1 Global Medically Assisted Reproduction Drugs Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Medically Assisted Reproduction Drugs Revenue by Manufacturer (2018-2023)
  • 3.3 Global Medically Assisted Reproduction Drugs Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Medically Assisted Reproduction Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Medically Assisted Reproduction Drugs Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Medically Assisted Reproduction Drugs Manufacturer Market Share in 2022
  • 3.5 Medically Assisted Reproduction Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Medically Assisted Reproduction Drugs Market: Region Footprint
    • 3.5.2 Medically Assisted Reproduction Drugs Market: Company Product Type Footprint
    • 3.5.3 Medically Assisted Reproduction Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medically Assisted Reproduction Drugs Market Size by Region
    • 4.1.1 Global Medically Assisted Reproduction Drugs Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Medically Assisted Reproduction Drugs Consumption Value by Region (2018-2029)
    • 4.1.3 Global Medically Assisted Reproduction Drugs Average Price by Region (2018-2029)
  • 4.2 North America Medically Assisted Reproduction Drugs Consumption Value (2018-2029)
  • 4.3 Europe Medically Assisted Reproduction Drugs Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Medically Assisted Reproduction Drugs Consumption Value (2018-2029)
  • 4.5 South America Medically Assisted Reproduction Drugs Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Medically Assisted Reproduction Drugs Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Medically Assisted Reproduction Drugs Sales Quantity by Type (2018-2029)
  • 5.2 Global Medically Assisted Reproduction Drugs Consumption Value by Type (2018-2029)
  • 5.3 Global Medically Assisted Reproduction Drugs Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Medically Assisted Reproduction Drugs Sales Quantity by Application (2018-2029)
  • 6.2 Global Medically Assisted Reproduction Drugs Consumption Value by Application (2018-2029)
  • 6.3 Global Medically Assisted Reproduction Drugs Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Medically Assisted Reproduction Drugs Sales Quantity by Type (2018-2029)
  • 7.2 North America Medically Assisted Reproduction Drugs Sales Quantity by Application (2018-2029)
  • 7.3 North America Medically Assisted Reproduction Drugs Market Size by Country
    • 7.3.1 North America Medically Assisted Reproduction Drugs Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Medically Assisted Reproduction Drugs Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Medically Assisted Reproduction Drugs Sales Quantity by Type (2018-2029)
  • 8.2 Europe Medically Assisted Reproduction Drugs Sales Quantity by Application (2018-2029)
  • 8.3 Europe Medically Assisted Reproduction Drugs Market Size by Country
    • 8.3.1 Europe Medically Assisted Reproduction Drugs Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Medically Assisted Reproduction Drugs Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medically Assisted Reproduction Drugs Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Medically Assisted Reproduction Drugs Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Medically Assisted Reproduction Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Medically Assisted Reproduction Drugs Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Medically Assisted Reproduction Drugs Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Medically Assisted Reproduction Drugs Sales Quantity by Type (2018-2029)
  • 10.2 South America Medically Assisted Reproduction Drugs Sales Quantity by Application (2018-2029)
  • 10.3 South America Medically Assisted Reproduction Drugs Market Size by Country
    • 10.3.1 South America Medically Assisted Reproduction Drugs Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Medically Assisted Reproduction Drugs Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medically Assisted Reproduction Drugs Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Medically Assisted Reproduction Drugs Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Medically Assisted Reproduction Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Medically Assisted Reproduction Drugs Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Medically Assisted Reproduction Drugs Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Medically Assisted Reproduction Drugs Market Drivers
  • 12.2 Medically Assisted Reproduction Drugs Market Restraints
  • 12.3 Medically Assisted Reproduction Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medically Assisted Reproduction Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medically Assisted Reproduction Drugs
  • 13.3 Medically Assisted Reproduction Drugs Production Process
  • 13.4 Medically Assisted Reproduction Drugs Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medically Assisted Reproduction Drugs Typical Distributors
  • 14.3 Medically Assisted Reproduction Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Medically Assisted Reproduction Drugs market size was valued at USD 9746.2 million in 2022 and is forecast to a readjusted size of USD 13480 million by 2029 with a CAGR of 4.7% during review period.
    Assisted reproductive drugs include ovulation-stimulating drugs, luteal support drugs, down-regulatory drugs, ovulation-inducing drugs, etc. From the perspective of the use of various drugs in the IVF process, ovulation-stimulating drugs accounted for the highest proportion, as high as 62%, luteal support drugs accounted for 20%, down-regulatory drugs accounted for 15%, and ovulation-inducing drugs accounted for 3%.
    The Global Info Research report includes an overview of the development of the Medically Assisted Reproduction Drugs industry chain, the market status of Hospital (Ovulation Stimulation Drugs, Luteal Support Medications), Research Institute (Ovulation Stimulation Drugs, Luteal Support Medications), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Medically Assisted Reproduction Drugs.
    Regionally, the report analyzes the Medically Assisted Reproduction Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Medically Assisted Reproduction Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Medically Assisted Reproduction Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Medically Assisted Reproduction Drugs industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ovulation Stimulation Drugs, Luteal Support Medications).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Medically Assisted Reproduction Drugs market.
    Regional Analysis: The report involves examining the Medically Assisted Reproduction Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Medically Assisted Reproduction Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Medically Assisted Reproduction Drugs:
    Company Analysis: Report covers individual Medically Assisted Reproduction Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Medically Assisted Reproduction Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Research Institute).
    Technology Analysis: Report covers specific technologies relevant to Medically Assisted Reproduction Drugs. It assesses the current state, advancements, and potential future developments in Medically Assisted Reproduction Drugs areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Medically Assisted Reproduction Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Medically Assisted Reproduction Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Ovulation Stimulation Drugs
    Luteal Support Medications
    Downregulatory Drugs
    Ovulation Inducing Drugs
    Market segment by Application
    Hospital
    Research Institute
    Others
    Major players covered
    Merck Serono
    MSD
    Livzon Pharmaceutical
    Xianju Pharmaceutical
    Kinsey Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Medically Assisted Reproduction Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Medically Assisted Reproduction Drugs, with price, sales, revenue and global market share of Medically Assisted Reproduction Drugs from 2018 to 2023.
    Chapter 3, the Medically Assisted Reproduction Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Medically Assisted Reproduction Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medically Assisted Reproduction Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Medically Assisted Reproduction Drugs.
    Chapter 14 and 15, to describe Medically Assisted Reproduction Drugs sales channel, distributors, customers, research findings and conclusion.

    Buy now